Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 237 Recurrence 24 Neoplasms, Plasma Cell 22 Immunoglobulin Light-chain Amyloidosis 18 Amyloidosis 10 Smoldering Multiple Myeloma 8 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Plasma Cell 4 Hodgkin Disease 4 Sezary Syndrome 3 Renal Insufficiency 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Plasmacytoma 3 Neoplasms 3 Nausea 3 Mycosis Fungoides 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Hematologic Neoplasms 3 Burkitt Lymphoma 3 Blast Crisis 3 Vomiting 2 Testicular Neoplasms 2

Interventions

Dexamethasone 6 Lenalidomide 4 Cyclophosphamide 4 Melphalan 3 daratumumab 2 carfilzomib 2 Prednisone 2 ricolinostat 1 pomalidomide 1 deltacortene 1 Transplantation, Autologous 1 Thalidomide 1 Calcium Dobesilate 1 Bortezomib 1 Bone Marrow Examination 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Calcium Dobesilate × Plasma cell × Clear all

NCT01857115 2024-11-13

wCCyd

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡